Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Propranolol hydrochloride 80 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Propranolol hydrochloride 80 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Propranolol hydrochloride 16 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Propranolol hydrochloride 16 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
2 |
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
2 |
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
2 |
Alprazolam 250 microgram and propranolol hydrochloride 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
2 |
Alprazolam 250 microgram and propranolol hydrochloride 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
2 |